NASDAQ$ARAY

Accuray Inc · Q4 2020 earnings

Q4 2020 earnings · · Investor relations

Briefing

Reported financial results for the fourth quarter and fiscal year ended June 30, 2020.

Accuray reported a solid performance in Q4 2020, with gross orders of $94.3 million and net revenue of $95.0 million. The company generated $19.2 million in operating cash flow and ended the quarter with $108.6 million in cash and short-term restricted cash. Despite a net loss of $0.8 million, Adjusted EBITDA was $9.3 million. The company's ending backlog increased by 22 percent from the prior year.

  • Gross orders of $94.3 million, including 8 orders from China.
  • Net revenue of $95.0 million, net loss of $0.8 million, Adjusted EBITDA of $9.3 million.
  • Generated $19.2 million of operating cash flow and ended the quarter with $108.6 million of cash and short-term restricted cash.
  • Shipped nine Synchrony upgrades.

Headline financials

Total Revenue

$95M

Previous: $117M-19.1%
EPS (adj)

-$0.01

Previous: -$0.02+50.0%
Gross Orders

$94.3M

Previous: $97.2M-3.0%
Adjusted EBITDA

$9.33M

Previous: $8.95M+4.3%
Net Income

-$823K

Previous: -$1.4M+41.2%
Operating Income

$4.56M

Previous: $3.26M+39.8%
Gross Profit

$39.9M

Previous: $45.9M-13.1%
Cash & Equivalents

$108M

Previous: $76.8M+40.1%
Total Assets

$490M

Previous: $438M+11.8%

Revenue & EPS history

Accuray · Revenue · Quarterly

$95M

Q4 2020-19.1%vs Q4 2019
Beat estimate in 7 of 15 quarters(47%)
ActualEstimate

Revenue by segment

Accuray · $95M total across 2 segments · Q4 2020

  • Services Revenue
    $54.6M-3.9%
  • Products Revenue
    $40.4M-33.4%

Forward guidance

Accuray believes it is prudent to refrain from providing revenue and adjusted EBITDA guidance for fiscal year 2021 due to the continued evolution of the COVID-19 pandemic and the uncertainty surrounding its impact on the global economy and the healthcare industry.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q4 2020

Historical avgQ4 2020

-0.1%

Avg return

Earnings day

+0.4%

Avg return

5 days after

-0.8%

Avg return

30 days after

47%

30 / 64 earnings

Positive

+49.7%

Q4 2024

Best reaction

-39.6%

Q3 2026

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2026-39.6%-35.4%
Q2 2026-21.1%-27.6%-35.5%
Q1 2026-15.9%-19.3%-31.7%
Q3 2025-12.9%-16.1%-1.3%
Q2 2025+8.0%-8.0%-25.3%
Q1 2025+8.9%+3.1%+4.7%
Q4 2024+49.7%+62.1%+51.0%
Q3 2024-27.7%-16.0%-16.9%
Q2 2024-5.2%-11.9%-3.3%
Q1 2024-0.7%-7.8%-1.1%
Q4 2023-23.2%-23.2%-35.9%
Q3 2023+14.4%+24.9%+31.0%
Q2 2023+14.3%+18.3%+19.4%
Q1 2023+1.5%+4.5%+2.5%
Q4 2022+27.5%+43.5%+15.0%
Q3 2022-10.2%-15.2%-31.4%
Q2 2022-15.9%-11.0%-13.2%
Q1 2022+9.7%+1.9%-9.3%
Q4 2021-3.7%-10.7%-9.2%
Q3 2021-11.1%-14.7%-22.9%
Q2 2021+4.1%-4.3%-3.3%
Q1 2021+2.5%+16.9%+51.4%
Q4 2020-6.6%-10.6%-17.2%
Q3 2020+26.3%+21.1%+10.0%
Q2 2020+13.4%+3.2%-21.2%
Q1 2020-4.8%-11.4%+5.5%
Q4 2019-15.5%-16.1%-9.6%
Q3 2019+1.7%+4.3%-5.5%
Q2 2019+14.2%+15.5%+36.2%
Q1 2019+32.8%+40.5%+20.1%
Q4 2018+11.5%+14.9%+9.2%
Q3 2018-15.3%-8.9%-10.9%
Q2 2018+8.7%+9.7%-1.9%
Q1 2018+3.5%+14.1%+24.7%
Q4 2017+5.1%+5.1%+14.1%
Q3 2017-5.2%-12.5%-13.5%
Q2 2017+1.8%+1.8%-2.7%
Q1 2017-5.7%-7.5%+0.0%
Q4 2016-8.8%-3.1%-0.5%
Q3 2016-7.1%
Q2 2016-12.2%
Q1 2016+6.3%
Q4 2015+10.2%
Q3 2015-22.4%
Q2 2015+6.0%
Q1 2015-15.9%
Q4 2014+2.6%
Q3 2014-8.9%
Q2 2014+19.4%
Q1 2014+11.4%
Q4 2013+5.1%
Q3 2013+12.2%
Q2 2013-12.4%
Q1 2013+0.0%
Q4 2010-2.8%
Q4 2012-9.3%
Q3 2011-9.4%
Q3 2012-9.4%
Q2 2012+16.6%
Q2 2011+16.6%
Q4 2011-3.5%
Q1 2011-3.5%
Q1 2012-3.5%
Q3 2010-0.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro